| Targeting the p300/CBP axis in lethal prostate cancer J Welti, A Sharp, N Brooks, W Yuan, C McNair, SN Chand, A Pal, ... Cancer Discovery 11 (5), 1118-1137, 2021 | 192 | 2021 |
| RB/E2F1 as a master regulator of cancer cell metabolism in advanced disease AC Mandigo, W Yuan, K Xu, P Gallagher, A Pang, YF Guan, AA Shafi, ... Cancer Discovery, 2021 | 65 | 2021 |
| Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance C Guo, A Sharp, B Gurel, M Crespo, I Figueiredo, S Jain, U Vogl, ... Nature, 1-3, 2023 | 56 | 2023 |
| B7-H3 as a therapeutic target in advanced prostate cancer C Guo, I Figueiredo, B Gurel, A Neeb, G Seed, M Crespo, S Carreira, ... European Urology 83 (3), 224-238, 2023 | 42 | 2023 |
| Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth E Scott, K Hodgson, B Calle, H Turner, K Cheung, A Bermudez, ... Oncogene 42 (12), 926-937, 2023 | 38 | 2023 |
| Assessment of Androgen Receptor splice variant-7 as a biomarker of clinical response in castration-sensitive prostate cancer AG Sowalsky, I Figueiredo, RT Lis, I Coleman, B Gurel, D Bogdan, ... Clinical Cancer Research 28 (16), 3509-3525, 2022 | 25 | 2022 |
| A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer CE Fletcher, L Deng, F Orafidiya, W Yuan, M Lorentzen, OW Cyran, ... Molecular Cancer 21 (1), 82, 2022 | 17 | 2022 |
| Novel oncogenic transcription factor cooperation in RB-deficient cancer AC Mandigo, AA Shafi, JJ McCann, W Yuan, TS Laufer, D Bogdan, ... Cancer Research 82 (2), 221-234, 2022 | 14 | 2022 |
| Critical role of antioxidant programs in enzalutamide-resistant prostate cancer EB Blatt, K Parra, A Neeb, L Buroni, D Bogdan, W Yuan, Y Gao, ... Oncogene, 1-13, 2023 | 6 | 2023 |
| A Transgender Patient with Prostate Cancer: Lessons Learnt K Chandran, R Grochot, MLDF De, L Maza, W Yuan, B Gurel, S Miranda, ... European urology 83 (4), 379-380, 2023 | 4 | 2023 |
| Thio-2 inhibits key signaling pathways required for the development and progression of castration resistant prostate cancer. A Neeb, I Figueiredo, D Bogdan, L Cato, J Stober, JM Jiménez-Vacas, ... Molecular Cancer Therapeutics, 2024 | 2 | 2024 |
| Long non-coding RNA NORAD interaction with miR-346 impacts DNA damage response and anti-tumor immunity in prostate cancer C Fletcher, L Deng, F Orafidiya, W Yuan, I Figueiredo, B Gurel, D Leach, ... Cancer Research 81 (13 Supplement), 2362-2362, 2021 | 2 | 2021 |
| Targeting the BAG-1 family of co-chaperones in lethal prostate cancer. A Neeb, I Figueiredo, D Bogdan, L Cato, J Strober, JM Jimenez-Vacas, ... bioRxiv, 2022 | | 2022 |
| A novel MiR-346-Directed DNA damage mechanism is regulated by its interaction with long non-coding RNA, NORAD, in prostate cancer C Fletcher, F Orafidiya, L Deng, W Yuan, M Lorentzen, O Cyran, ... Endocrine Abstracts 77, 2021 | | 2021 |
Wei YuanInstitute of Cancer ResearchEmail verificata su icr.ac.uk